Quantify changes in collagen content in Pancreatic Ductal Adenocarcinoma (PDAC) research models with Collagen Hybridizing Peptides (CHPs) to assess stromal-targeted therapies, desmoplastic growth, and PDAC metastasis.
CHP staining intensity serves as a marker for the degree of collagen remodeling, which is a hallmark of fibrotic disease activity and progression
Accurately mapping collagen distribution and changes within the TME is crucial for effective interrogation of PDAC tumors. PDAC is notoriously challenging to treat due to its dense, collagen-rich desmoplastic stroma, which creates a barrier to immune cell infiltration, hindering drug delivery and promoting tumor progression.
Explore the potential of CHPs to overcome the challenges of PDAC research. Download our application note to discover how CHPs can transform your understanding of the PDAC tumor microenvironment.
CHPs enable the precise measurement of inflammation and tissue damage in a number of conditions.
Our CHP products are conjugated with a variety of detection motifs for brightfield and fluorescence detection, and they can be customized to meet your unique needs. Visit our products page to learn more.
Our experts are here to help.
Contact UsThanks for subscribing!
This email has been registered!